Epiregulin Antibodies

Santa Cruz Biotechnology features a diverse variety of Epiregulin monoclonal antibodies for research focused on understanding epiregulin's role in various biological processes. Epiregulin monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Epiregulin is a member of the epidermal growth factor (EGF) family and plays a crucial role in cell proliferation, differentiation, and survival. Research has shown epiregulin's significant impact on cancer biology through its influence on tumor growth and metastasis via interactions with EGF receptors. Understanding epiregulin function continues to be vital for developing targeted therapies and advancing cancer research. Epiregulin expression patterns have been observed across multiple tissue types, making it an important target for developmental biology studies. Recent discoveries have highlighted epiregulin's involvement in wound healing and tissue repair mechanisms. Ongoing research continues to uncover new functions of epiregulin in cellular signaling pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of epiregulin's biological significance and potential therapeutic applications.